Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Insight into the Evolving Role of PCSK9
Mateusz Maligłówka, Michał Kosowski, Marcin Hachuła, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 256-256
Open Access | Times Cited: 32
The association between a novel inflammatory biomarker, systemic inflammatory response index and the risk of diabetic cardiovascular complications
Kaibin Lin, Lan Yang, Wang Ai, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 7, pp. 1389-1397
Closed Access | Times Cited: 22
Chronic PCSK9 inhibitor therapy leads to sustained improvements in endothelial function, arterial stiffness, and microvascular function
Johanna Schremmer, Lucas Busch, S. Baasen, et al.
Microvascular Research (2023) Vol. 148, pp. 104513-104513
Closed Access | Times Cited: 18
Exploring neutrophils as therapeutic targets in cardiometabolic diseases
Mattia Albiero, Andrea Baragetti
Trends in Pharmacological Sciences (2025)
Closed Access
Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - an observational study
Matthias P. Nägele, Yannik Raemy, Leonie Kreysing, et al.
Journal of clinical lipidology (2025)
Closed Access
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation
Francesco Barbagallo, Giosiana Bosco, Maurizio Di Marco, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
Petros Adamidis, Despoina Pantazi, Iraklis C. Moschonas, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 3, pp. 72-72
Open Access | Times Cited: 3
PCSK9 in T-cell function and the immune response
Yuying Wang, Xiaosheng Fang, Jiarui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials
Haibing Dai, Yonglin Zhu, Zuyi Chen, et al.
Endokrynologia Polska (2023) Vol. 74, Iss. 3, pp. 234-242
Open Access | Times Cited: 7
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis
Giosiana Bosco, Francesco Barbagallo, Maurizio Di Marco, et al.
European Journal of Internal Medicine (2024) Vol. 132, pp. 118-126
Open Access | Times Cited: 2
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation
Marcella Palumbo, Antonina Giammanco, Francesco Purrello, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 11
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units
Roberto Scicali, Giuseppe Mandraffino, Antonino Di Pino, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 12, pp. 3401-3406
Closed Access | Times Cited: 12
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
Bíborka Nádró, Hajnalka Lőrincz, Lilla Juhász, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 771-771
Open Access | Times Cited: 6
Effects of proprotein convertase subtilisin-kexin type 9 inhibitors on inflammatory and hemostatic parameters in post myocardial infarction patients
Andreja Rehberger Likozar, Sabina Ugovšek, Miran Šebeštjen
European Journal of Pharmacology (2023) Vol. 963, pp. 176232-176232
Open Access | Times Cited: 2
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
Roberto Scicali, Giuseppe Mandraffino, Michele Scuruchi, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1715-1715
Open Access | Times Cited: 4
PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials
Jichang Luo, Wanying Liao, Xue Wang, et al.
BMJ Open (2022) Vol. 12, Iss. 11, pp. e062046-e062046
Open Access | Times Cited: 3
PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from mendelian randomization, cohort studies and basic experiments
Linghao Xu, Liang Wang, Yuanqi Wang, et al.
Research Square (Research Square) (2024)
Open Access
a. Part I: Treatment of Abnormalities in Lipid Metabolism and EVA
Vasilios Kotsis
Elsevier eBooks (2024), pp. 441-445
Closed Access
PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from Mendelian randomization, a retrospective study and basic experiments
Linghao Xu, Liang Wang, Yuanqi Wang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Predictive value of peripheral neutrophil count on admission for young patients with acute coronary syndrome
Jia Zheng, Tingting Li, Fang Hu, et al.
The American Journal of the Medical Sciences (2024)
Open Access
A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients
Fangyuan Li, Pucong Ye, Yu Hao, et al.
Atherosclerosis Plus (2022) Vol. 49, pp. 12-19
Open Access | Times Cited: 2
Relationship between lipid parameters and vascular mechanical characteristics among a normotensive population without diabetes mellitus residing at the Qinghai–Tibet plateau: a cross-sectional study
Xianjin Hu, Xin Zhang, Zhipeng Zhang, et al.
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Monocyte to high-density lipoprotein ratio presents a linear association with atherosclerosis and nonlinear association with arteriosclerosis in elderly Chinese population: The Northern Shanghai Study
Song Zhao, Jiamin Tang, Shikai Yu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 33, Iss. 3, pp. 577-583
Closed Access | Times Cited: 1
PCSK9 inhibitors attenuates arterial stiffness in patients with acute coronary syndrome
Liang Wang, Ruijie Wang, Tiantian Jiao, et al.
Research Square (Research Square) (2023)
Open Access
PCSK9 Inhibitor Induces a Transient Decrease in Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio in Homozygous/Compound Heterozygous Familial Hypercholesterolemia Patients
Fang Yuan Li, Pucong Ye, Yu Hao, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top